Opendata, web and dolomites

SURE SIGNED

3-D Super resolution Ultrasound Real time imaging of Erythrocytes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SURE project word cloud

Explore the words cloud of the SURE project. It provides you a very rough idea of what is the project "SURE" about.

sure    paradigm    times    cm    ultrafast    effort    vascular    volumetric    leads    breakthroughs    newborns    aperture    clinical    visualizing    diagnoses    pressure    agents    scientific    repeated    probes    column    diabetes    adverse    resolution    visualization    injection    synergistic    shift    flow    thereby    perfusion    levels    hz    quantification    groups    estimation    disease    screening    time    2600    capillary    rates    attained    hundreds    anatomy    400    isotropic    volume    normal    frame    diagnostic    coded    million    tracks    synthetic    full    diagnosis    treatment    population    super    goals    cancer    elderly    micrometer    contrast    gbytes    ultrasound    silicon    erythrocytes    faster    dimensional    volumes    resolving    directions    yield    performed    detecting    cells    red    imaging    deep    row    individual    motion    learning    trials    humans    combing    tracking    rodents    body    blood    human    gradient    13    data    possibility   

Project "SURE" data sheet

The following table provides information about the project.

Coordinator
DANMARKS TEKNISKE UNIVERSITET 

Organization address
address: ANKER ENGELUNDSVEJ 1 BYGNING 101 A
city: KGS LYNGBY
postcode: 2800
website: www.dtu.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 9˙980˙899 €
 EC max contribution 9˙980˙899 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-SyG
 Funding Scheme ERC-SyG
 Starting year 2020
 Duration (year-month-day) from 2020-03-01   to  2026-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) coordinator 7˙384˙019.00
2    REGION HOVEDSTADEN DK (HILLEROD) participant 1˙431˙565.00
3    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 1˙165˙315.00

Map

 Project objective

'The SURE project: 'Super resolution Ultrasound Real time imaging of Erythrocytes' will develop and research a new super resolution ultrasound imaging method capable of resolving capillary flow in the human body. The approach tracks the motion of the individual red blood cells (erythrocytes) in a three-dimensional volume for a full visualization of anatomy, flow, and perfusion in a volume down to 13 cm at 20 volumes per second. The super resolution imaging is performed without using contrast agents and is thereby 2600 times faster than current methods. The method has an isotropic resolution of 50 micrometer in all directions, and the volumetric resolution is thereby 100-400 times better than current state-of-the-art 3-D ultrasound imaging. These highly ambitious goals are attained in a synergistic research effort combing four research groups. The scientific project includes breakthroughs in silicon row-column probes with 1 million elements, advanced synthetic aperture ultrafast coded imaging, deep learning for detecting and tracking of cells, pressure gradient estimation, and visualization and quantification of several hundreds of Gbytes volumetric data. The research finally leads to clinical trials conducted on rodents and humans for studying the changes in perfusion for diabetes and cancer. The SURE imaging approach can yield a paradigm shift in the scientific study, diagnoses, and treatment of cancer, diabetes, and vascular disease at the capillary level, as it enables the possibility of volumetric visualizing capillary perfusion in real-time at frame rates above 20 Hz without injection of contrast agents. Imaging is performed using ultrasound at normal diagnostic levels with no known adverse effects and can, thus, be used on a wide range of the population from newborns to the elderly for both diagnosis and repeated screening.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More